A detailed history of Tealwood Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tealwood Asset Management Inc holds 1,731 shares of REGN stock, worth $1.77 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
1,731
Previous 1,748 0.97%
Holding current value
$1.77 Million
Previous $1.54 Million 8.53%
% of portfolio
0.75%
Previous 0.73%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$902.69 - $993.35 $15,345 - $16,886
-17 Reduced 0.97%
1,731 $1.67 Million
Q4 2023

Jan 08, 2024

SELL
$775.18 - $881.7 $19,379 - $22,042
-25 Reduced 1.41%
1,748 $1.54 Million
Q3 2023

Nov 08, 2023

BUY
$692.45 - $844.37 $22,158 - $27,019
32 Added 1.84%
1,773 $1.46 Million
Q2 2023

Jul 26, 2023

SELL
$700.03 - $830.35 $5,600 - $6,642
-8 Reduced 0.46%
1,741 $1.25 Million
Q1 2023

Apr 12, 2023

SELL
$680.49 - $826.97 $462,052 - $561,512
-679 Reduced 27.97%
1,749 $1.44 Million
Q4 2022

Jan 17, 2023

SELL
$705.89 - $766.39 $93,177 - $101,163
-132 Reduced 5.16%
2,428 $1.75 Million
Q3 2022

Nov 16, 2022

SELL
$573.97 - $724.32 $20,662 - $26,075
-36 Reduced 1.39%
2,560 $1.76 Million
Q2 2022

Jul 20, 2022

SELL
$548.35 - $738.84 $33,449 - $45,069
-61 Reduced 2.3%
2,596 $1.54 Million
Q1 2022

May 02, 2022

SELL
$595.12 - $698.43 $17,258 - $20,254
-29 Reduced 1.08%
2,657 $1.86 Million
Q4 2021

Mar 15, 2022

SELL
$543.48 - $670.97 $108,152 - $133,523
-199 Reduced 6.9%
2,686 $1.7 Million
Q3 2021

Dec 02, 2021

BUY
$574.03 - $680.96 $323,752 - $384,061
564 Added 24.3%
2,885 $1.75 Million
Q1 2021

Jun 21, 2021

BUY
$446.73 - $548.2 $18,315 - $22,476
41 Added 1.8%
2,321 $1.1 Million
Q4 2020

Mar 09, 2021

BUY
$478.3 - $607.98 $1.09 Million - $1.39 Million
2,280 New
2,280 $1.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $110B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.